Metabolic syndrome and amnestic mild cognitive impairment: Singapore longitudinal ageing study-2 findings

Journal of Alzheimer's Disease

Volumn 34, Issue 3, 2013, Pages 649-657

  Feng, Liang ^a   Chong, Mei Sian ^a,b   Lim, Wee Shiong ^a,b   Lee, Tih Shih ^a,c   Collinson, Simon L ^d   Yap, Philip ^a,e   Ng, Tze Pin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e ALEXANDRA HOSPITAL   (Singapore)

Author keywords

Amnestic mild cognitive impairment; APOE 4; cognition; metabolic syndrome

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EDUCATION; FEMALE; GENDER; GERIATRIC DEPRESSION SCALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; LEISURE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; SINGAPORE; SMOKING;

EID: 84876382213     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121885     Document Type: Article

References (69)

1. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359. (Pubitemid 34251969)
2. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J (2008) The metabolic syndrome predicts incident stroke:A14-year follow-up study in elderly people in Finland. Stroke 39, 1078-1083. (Pubitemid 351444669)
3. Gami AS,Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM (2007) Metabolic syndrome and risk of incident cardiovascular events and death:Asystematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49, 403-414. (Pubitemid 46135879)
4. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21, 57-63.
5. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology 67, 843-847. (Pubitemid 44394200)
6. Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64, 93-96. (Pubitemid 46072429)
7. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192. (Pubitemid 47312668)
8. Forti P, Pisacane N, Rietti E, Lucicesare A, OlivelliV, Mariani E, Mecocci P, RavagliaG(2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58, 487-492.
9. Kalmijn S, Foley D,White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20, 2255-2260.
10. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 32, 169-174.
11. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, FrisardiV,Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F (2010) Metabolic syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 81, 433-440.
12. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C (2009) Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 66, 1151-1157.
13. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
14. Roberts RO, Geda YE, Knopman DS, Cha RH, Boeve BF, Ivnik RJ, Pankratz VS, Tangalos EG, Petersen RC (2010) Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord 24, 11-18.
15. Yaffe K, Weston AL, Blackwell T, Krueger KA (2009) The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 66, 324-328.
16. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F (2011) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 32, 1932-1941.
17. Bookheimer S, Burggren A (2009) APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol 5, 343-362.
18. Modrego PJ (2006) Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res 3, 161-170.
19. van Duijn CM, de Knijff P, Cruts M,Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7, 74-78. (Pubitemid 24232384)
20. Niti M, Yap KB, Kua EH, Tan CH, Ng TP (2008) Physical, social and productive leisure activities, cognitive decline and interaction with APOE-epsilon 4 genotype in Chinese older adults. Int Psychogeriatr 20, 237-251. (Pubitemid 351230234)
21. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J (2006) Mild cognitive impairment (MCI) in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry 77, 714-718. (Pubitemid 43837193)
22. Lee CK, Collinson SL, Feng L, Ng TP (2012) Preliminary normative neuropsychological data for an elderly chinese population. Clin Neuropsychol 26, 321-334.
23. Lezak MD (1995) Neuropsychological Assessment 3rd ed, Oxford University Press, New York.
24. Benedict HRB (1997) Brief Visuospatial Memory Test-Revised professional manual. Psychological Assessment Resources, Inc., Odessa, FL.
25. Mahoney FI, Barthel DW (1965) Functional evaluation: The Barthel Index. Md State Med J 14, 61-65.
26. Feng L, Chong MS, Lim WS, Ng TP (2012) The Modified Mini-Mental State Examination test: Normative data for Singapore Chinese older adults and its performance in detecting early cognitive impairment. Singapore Med J 53, 458-462.
27. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699. (Pubitemid 41623495)
28. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572. (Pubitemid 12124384)
29. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R (2008) Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: A Texas Alzheimer's research consortium study. Arch Neurol 65, 1091-1095.
30. D' elia LS, P, Uchiyama CL, White T (1996) Color Trails Test. Psychological Assessment Resources Inc., Lutz, FL.
31. Wechsler D (1998)Wechsler Adult Intelligence Scale Revised (WAIS-R). Versione Italiana a cura di Laicardi eOrsini, Organizzazioni Speciali, Firenze.
32. Wechsler D (1997) WAIS-III Administration and Scoring Manual. Psychological Corporation, San Antonio, TX.
33. Cheung RW, Cheung MC, Chan AS (2004) Confrontation naming in Chinese patients with left, right or bilateral brain damage. J Int Neuropsychol Soc 10, 46-53. (Pubitemid 38128461)
34. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366, 1059-1062. (Pubitemid 41338752)
35. Yesavage JA (1988) Geriatric Depression Scale. Psychopharmacol Bull 24, 709-711.
36. Broekman BF, Nyunt SZ, Niti M, Jin AZ, Ko SM, Kumar R, Fones CS, Ng TP (2008) Differential item functioning of the Geriatric Depression Scale in an Asian population. J Affect Disord 108, 285-290. (Pubitemid 351615440)
37. Nyunt MS, Fones C, Niti M, Ng TP (2009) Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of communityliving Asian older adults. Aging Ment Health 13, 376-382.
38. Hassenstab JJ, SweatV, Bruehl H, ConvitA(2010) Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord 29, 356-362.
39. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660. (Pubitemid 47547816)
40. Ho RC, Niti M, Yap KB, Kua EH, Ng TP (2008) Metabolic syndrome and cognitive decline in chinese older adults: Results from the singapore longitudinal ageing studies. Am J Geriatr Psychiatry 16, 519-522.
41. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762. (Pubitemid 46668964)
42. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242. (Pubitemid 39473161)
43. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J,Westendorp RG (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985. (Pubitemid 47366051)
44. Laudisio A, Marzetti E, Pagano F, Cocchi A, Franceschi C, Bernabei R, Zuccala G (2008) Association of metabolic syndrome with cognitive function: The role of sex and age. Clin Nutr 27, 747-754.
45. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL,Tuomilehto J, Soininen H, NissinenA (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560. (Pubitemid 41434560)
46. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057-1064.
47. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163, 1524-1528. (Pubitemid 36835095)
48. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P (2003) Body mass index and incidence of dementia: The PAQUID study. Neurology 60, 117-119. (Pubitemid 36070657)
49. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897. (Pubitemid 41362136)
50. White H, Pieper C, Schmader K, FillenbaumG(1996)Weight change in Alzheimer's disease. J AmGeriatr Soc 44, 265-272. (Pubitemid 26081092)
51. Luchsinger JA, Gustafson DR (2009) Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis 16, 693-704.
52. Davignon J (2005) Apolipoprotein E and atherosclerosis: Beyond lipid effect. Arterioscler Thromb Vasc Biol 25, 267-269. (Pubitemid 40189142)
53. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, MartinsRN(2006) Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11, 721-736. (Pubitemid 44141805)
54. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137, 149-155. (Pubitemid 34827510)
55. Myers RH, Schaefer EJ,Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46, 673-677.
56. Carmelli D, Swan GE, Reed T, Miller B,Wolf PA, Jarvik GP, Schellenberg GD (1998) Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 50, 1580-1585. (Pubitemid 28283221)
57. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOEgene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262. (Pubitemid 34438377)
58. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282, 40-46. (Pubitemid 29318931)
59. Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64, 268-276.
60. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 66, 300-305.
61. Tay LBG, Chong MS, Chan M, Sitoh YY, Lim WS (2012) Aggregation of vascular risk factors and neuropsychological performance in early Alzheimer's disease. JARCP 1, 109-114.
62. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 47, 1643-1649. (Pubitemid 28445355)
63. NestoRW(2003) The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med 4(Suppl 6), S11-S18. (Pubitemid 37526931)
64. Craft S, Reger MA, Baker LD (2006) Insulin resistance in Alzheimer's disease - a novel therapeutic target. In Alzheimer's Disease and Related Disorders Annual 5, Gauthier S, Scheltens P, Cummings JL, eds. Taylor and Francis, London pp. 111-133.
65. Grossman H (2003) Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. CNS Spectr 8, 815-823.
66. Nieto-Vazquez I, Fernandez-Veledo S, Kramer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M (2008) Insulin resistance associated to obesity: The link TNF-alpha. Arch Physiol Biochem 114, 183-194. (Pubitemid 352009305)
67. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T (2002) Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113, 607-615. (Pubitemid 34874684)
68. Harvey J (2003) Leptin:Amultifaceted hormone in the central nervous system. Mol Neurobiol 28, 245-258. (Pubitemid 38156422)
69. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N (2004) Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 18, 1870-1878. (Pubitemid 39602272)